4//SEC Filing
Monroe Terilyn J. 4
Accession 0001652956-25-000005
CIK 0001576280other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 9:30 PM ET
Size
23.6 KB
Accession
0001652956-25-000005
Insider Transaction Report
Form 4
Monroe Terilyn J.
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-01$20.14/sh+35,000$704,900→ 61,087 total - Exercise/Conversion
Common Stock
2025-12-01$28.61/sh+15,000$429,150→ 76,087 total - Sale
Common Stock
2025-12-01$105.33/sh−18,576$1,956,610→ 57,511 total - Sale
Common Stock
2025-12-01$106.15/sh−23,974$2,544,840→ 33,537 total - Sale
Common Stock
2025-12-01$106.90/sh−6,786$725,423→ 26,751 total - Sale
Common Stock
2025-12-01$107.85/sh−664$71,612→ 26,087 total - Sale
Common Stock
2025-12-01$105.33/sh−1,923$202,550→ 24,164 total - Sale
Common Stock
2025-12-01$106.18/sh−2,444$259,504→ 21,720 total - Sale
Common Stock
2025-12-01$107.03/sh−800$85,624→ 20,920 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-01−35,000→ 43,204 totalExercise: $20.14Exp: 2034-02-26→ Common Stock (35,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-01−15,000→ 32,627 totalExercise: $28.61Exp: 2034-11-08→ Common Stock (15,000 underlying)
Footnotes (9)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.625 to $105.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.625 to $106.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.625 to $107.560. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.730 to $107.970. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.680 to $105.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.680 to $106.670. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.710 to $107.770. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F8]This represents a stock option granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 2, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
- [F9]This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001652956
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 9:30 PM ET
- Size
- 23.6 KB